4.3 Review

Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway

Journal

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
Volume 2018, Issue -, Pages -

Publisher

HINDAWI LTD
DOI: 10.1155/2018/5438179

Keywords

-

Categories

Funding

  1. National Science Foundation of China [81570344]
  2. Norman Bethune Program of Jilin University [2015225, 2015203]
  3. Jilin Provincial Science and Technology Foundations [20180414039GH, 20150204093SF]
  4. Education Department of Jilin Province Foundations [2016-448]
  5. Health and Family Planning Commission of Jilin Province Foundations [2016Q034, 2015Q010]

Ask authors/readers for more resources

Sulforaphane (SFN), a compound derived from cruciferous vegetables that has been shown to be safe and nontoxic, with minimal/no side effects, has been extensively studied due to its numerous bioactivities, such as anticancer and antioxidant activities. SFN exerts its anticancer effects by modulating key signaling pathways and genes involved in the induction of apoptosis, cell cycle arrest, and inhibition of angiogenesis. SFN also upregulates a series of cytoprotective genes by activating nuclear factor erythroid-2-(NF-E2-) related factor 2 (Nrf2), a critical transcription factor activated in response to oxidative stress; Nrf2 activation is also involved in the cancer-preventive effects of SFN. Accumulating evidence supports that epigenetic modification is an important factor in carcinogenesis and cancer progression, as epigenetic alterations often contribute to the inhibition of tumor-suppressor genes and the activation of oncogenes, which enables cells to acquire cancer-promoting properties. Studies on the mechanisms underlying the anticancer effects of SFN have shown that SFN can reverse such epigenetic alterations in cancers by targeting DNA methyltransferases (DNMTs), histone deacetyltransferases (HDACs), and noncoding RNAs. Therefore, in this review, we will discuss the anticancer activities of SFN and its mechanisms, with a particular emphasis on epigenetic modifications, including epigenetic reactivation of Nrf2.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Oncology

Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy

Bin Wang, Qin Zhao, Yuyu Zhang, Zijing Liu, Zhuangzhuang Zheng, Shiyu Liu, Lingbin Meng, Ying Xin, Xin Jiang

Summary: Hypoxic tumor microenvironment (TME) may be a major barrier limiting the efficacy of immunotherapy, through inducing immune suppression and resistance. Targeting hypoxia could enhance the efficacy of immunotherapy and provide a promising combinational therapeutic strategy.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Medicine, General & Internal

Radiotherapy of granulomatosis with polyangiitis occurring in the eyelid A case report and literature review

Jinlong Wei, Qin Zhao, Min Yao, Lingbin Meng, Ying Xin, Xin Jiang

Summary: A 29-year-old male patient with GPA exclusively in the eyelid area underwent successful radiotherapy, leading to a significant reduction of the lesion and obvious symptom relief. This case highlights the importance of considering novel treatments such as radiotherapy for GPA patients when the standard treatment model fails to deliver positive results.

MEDICINE (2021)

Review Medicine, Research & Experimental

Vascular normalization in immunotherapy: A promising mechanisms combined with radiotherapy

Zijing Liu, Qin Zhao, Zhuangzhuang Zheng, Shiyu Liu, Lingbin Meng, Lihua Dong, Xin Jiang

Summary: The study focuses on the mechanism of immunotherapy in normalizing tumor blood vessels and proposes a promising prospect for improving hypoxia. Immune checkpoint inhibitors induce the reduction in regulatory T cells and increase in eosinophil levels, playing crucial roles in the process of vascular normalization. This review suggests a new idea for the combined application of immunotherapy and radiotherapy, with the potential to pave the way for a promising strategy for cancer treatment.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Review Medicine, Research & Experimental

Progress and prospect in tumor treating fields treatment of glioblastoma

Shiyu Liu, Weiyan Shi, Qin Zhao, Zhuangzhuang Zheng, Zijing Liu, Lingbin Meng, Lihua Dong, Xin Jiang

Summary: TTFields is a treatment technology that induces apoptosis of cancer cells by generating an electric field, and is promising for the treatment of glioblastoma with few side effects.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Research progress on mechanism and imaging of temporal lobe injury induced by radiotherapy for head and neck cancer

Zhuangzhuang Zheng, Bin Wang, Qin Zhao, Yuyu Zhang, Jinlong Wei, Lingbin Meng, Ying Xin, Xin Jiang

Summary: Radiotherapy is effective in the treatment of head and neck cancer, but can lead to serious complications such as radiation-induced temporal lobe injury (TLI). Various imaging techniques such as CT and MRI can be used to observe structural changes and dose-dependent alterations in gray and white matter volume. Further advanced imaging modalities like DTI, DKI, SWI, rs-fMRI, MRS, and PET can help in early diagnosis and prognosis evaluation of TLI based on functional, molecular, and cellular processes.

EUROPEAN RADIOLOGY (2022)

Review Immunology

Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus

Huanhuan Wang, Qin Zhao, Yuyu Zhang, Qihe Zhang, Zhuangzhuang Zheng, Shiyu Liu, Zijing Liu, Lingbin Meng, Ying Xin, Xin Jiang

Summary: Head and neck cancer, primarily head and neck squamous cell carcinoma, is commonly treated with surgery, radiotherapy, chemotherapy, and immunotherapy. Immunotherapy, particularly for HPV-positive patients, has shown promising results possibly due to higher immune cell infiltration and differential expression of immune checkpoints in tumors. Personalized immunotherapy trials are also being conducted in HPV-positive patients.

FRONTIERS IN IMMUNOLOGY (2021)

Review Pharmacology & Pharmacy

Efficacy and safety of systemic treatments for patients with recurrent/ metastatic head and neck squamous cell carcinoma: A systematic review and network meta-analysis

Huanhuan Wang, Qin Zhao, Yangyu Zhang, Jinlong Wei, Bin Wang, Zhuangzhuang Zheng, Shiyu Liu, Zijing Liu, Lingbin Meng, Ying Xin, Xin Jiang

Summary: The study found that for recurrent/metastatic head and neck squamous cell carcinoma, chemotherapy regimens such as cetuximab/platinum/5-FU, pembrolizumab/platinum/5-FU or pembrolizumab alone, and nivolumab showed better efficacy with lower rates of adverse events. Immunotherapy has achieved better efficacy in treating the condition.

PHARMACOLOGICAL RESEARCH (2021)

Article Multidisciplinary Sciences

Systematic quantitative evaluation of Plan-IQ for intensity-modulated radiation therapy after modified radical mastectomy

Kunzhi Chen, Zhuangzhuang Zheng, Lijuan Ding, Na Tao, Libo Wang, Wenming Xia, Huidong Wang, Xin Jiang

Summary: A systematic quantitative evaluation of IMRT quality change in modified radical mastectomy using Plan-IQ feasibility tool was conducted. Results showed that the RP group had significantly better OAR dose limits compared to the NP group, with a decrease in total scores. PTV scores decreased in the RP group, while OAR scores improved.

SCIENTIFIC REPORTS (2021)

Review Biochemistry & Molecular Biology

Prospective Application of Ferroptosis in Hypoxic Cells for Tumor Radiotherapy

Jing Su, Qin Zhao, Zhuangzhuang Zheng, Huanhuan Wang, Chenbin Bian, Lingbin Meng, Ying Xin, Xin Jiang

Summary: Radiation therapy plays a crucial role in cancer treatment, but the hypoxic microenvironment in solid tumors can affect its effectiveness. Ferroptosis, a newly discovered cell death mechanism, can enhance the radiosensitivity of hypoxic tumor cells by amplifying oxidative stress or inhibiting antioxidant regulation.

ANTIOXIDANTS (2022)

Review Biochemistry & Molecular Biology

Unveiling the Vital Role of Long Non-Coding RNAs in Cardiac Oxidative Stress, Cell Death, and Fibrosis in Diabetic Cardiomyopathy

Yuan Tian, Ziting Gao, Wenyun Liu, Jinjie Li, Xin Jiang, Ying Xin

Summary: Diabetic cardiomyopathy is a major cause of mortality and morbidity in diabetes patients. Its pathogenesis involves multiple factors, and recent studies have found that long non-coding RNAs play a critical role in this process, providing insights for the development of diagnostic and therapeutic strategies.

ANTIOXIDANTS (2022)

Review Biochemistry & Molecular Biology

Targeting Mitochondrial Metabolism to Reverse Radioresistance: An Alternative to Glucose Metabolism

Chenbin Bian, Zhuangzhuang Zheng, Jing Su, Huanhuan Wang, Sitong Chang, Ying Xin, Xin Jiang

Summary: Radiotherapy failure and poor tumor prognosis are mainly caused by radioresistance. The relationship and mechanisms between mitochondrial metabolism and cancer radioresistance are not fully understood. However, mitochondria play a crucial role in regulating various biological reactions and influencing the radiation effects of malignancies. Therefore, targeting mitochondrial signaling pathways for the development of novel anticancer drugs holds promise.

ANTIOXIDANTS (2022)

Article Biochemistry & Molecular Biology

LncRNA MHRT Prevents Angiotensin II-Induced Myocardial Oxidative Stress and NLRP3 Inflammasome via Nrf2 Activation

Pinyi Liu, Xiaoming Dong, Chao Dong, Guowen Hou, Wenyun Liu, Xin Jiang, Ying Xin

Summary: MHRT exerts a protective effect against Ang II-induced myocardial injury by reducing oxidative stress and NLRP3 inflammasome activation via Nrf2 activation.

ANTIOXIDANTS (2023)

Review Pharmacology & Pharmacy

Impact of the gut microbiota on angiotensin II-related disorders and its mechanisms

Wei Liu, Zining Tan, Mengrou Geng, Xin Jiang, Ying Xin

Summary: This article discusses the relationship between the renin-angiotensin system (RAS) and the gut microbiota, noting that Angiotensin II (Ang II) can lead to an imbalance in the gut microbiota, thereby exacerbating disease progression. In addition, angiotensin converting enzyme 2 can alleviate the deleterious effects of Ang II and regulate gut microbial dysbiosis and immune responses associated with coronavirus disease 19. Deciphering these mechanisms will provide a theoretical basis for novel therapeutic strategies for disease prevention and treatment. Finally, therapies targeting the gut microbiota to treat Ang II-related disorders are discussed.

BIOCHEMICAL PHARMACOLOGY (2023)

Review Biochemistry & Molecular Biology

Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms

Bin Wang, Yin Han, Yuyu Zhang, Qin Zhao, Huanhuan Wang, Jinlong Wei, Lingbin Meng, Ying Xin, Xin Jiang

Summary: Immune checkpoint inhibitors (ICIs) targeting CTLA-4 and PD-1/PD-L1 have shown promise in treating various types of malignancies by boosting tumor-specific T cell immunity. However, acquired resistance to ICI therapy remains a major obstacle. In this review, we discuss the mechanisms of acquired resistance to ICIs, including lack of neoantigens, mutations in IFN-γ/JAK signaling, activation of alternate inhibitory immune checkpoints, immunosuppressive tumor microenvironment, epigenetic modification, and dysbiosis of the gut microbiome. Potential therapeutic strategies to reverse ICI resistance are also briefly explored.

CELL AND BIOSCIENCE (2023)

Review Oncology

Advances in radiotherapy and comprehensive treatment of high-grade glioma: immunotherapy and tumor-treating fields

Shiyu Liu, Qin Zhao, Weiyan Shi, Zhuangzhuang Zheng, Zijing Liu, Lingbin Meng, Lihua Dong, Xin Jiang

Summary: High-grade gliomas (HGGs) are the most common primary malignant brain tumors, and treatment plans are personalized based on patient characteristics. The basic treatment plan involves surgery, radiotherapy, and chemotherapy, while comprehensive treatment schemes combine various modalities such as radiotherapy, chemotherapy, molecular targeted therapy, and immunotherapy.

JOURNAL OF CANCER (2021)

No Data Available